These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26079033)

  • 21. Genetic tests for familial hypercholesterolemia.
    Day I; Humphries S
    Nat Biotechnol; 1996 Oct; 14(10):1227-8. PubMed ID: 9631083
    [No Abstract]   [Full Text] [Related]  

  • 22. Results and Lessons of a Pilot Study of Cascade Screening for Familial Hypercholesterolemia in US Primary Care Practices.
    Neuner J; Dimmock D; Kirschner AP; Beaudry H; Paradowski J; Orlando L
    J Gen Intern Med; 2020 Jan; 35(1):351-353. PubMed ID: 31667742
    [No Abstract]   [Full Text] [Related]  

  • 23. Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study.
    Sheth S; Lee P; Bajaj A; Cuchel M; Hajj J; Soffer DE; Webb G; Hossain E; Borovskiy Y; Risman M; Myers KD; Wilemon KA; Rader DJ; Jacoby D
    Circ Cardiovasc Qual Outcomes; 2021 Jun; 14(6):e007641. PubMed ID: 34107738
    [No Abstract]   [Full Text] [Related]  

  • 24. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Daniels SR; Gidding SS; de Ferranti SD;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S30-7. PubMed ID: 21600527
    [No Abstract]   [Full Text] [Related]  

  • 25. Detecting familial hypercholesterolaemia in general practice.
    Kirke A; Watts GF; Emery J
    Aust Fam Physician; 2012 Dec; 41(12):965-8. PubMed ID: 23210121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous familial hypercholesterolemia.
    Cesur Y; Caksen H
    Indian Pediatr; 2001 Mar; 38(3):305-6. PubMed ID: 11255318
    [No Abstract]   [Full Text] [Related]  

  • 27. People at risk of familial hypercholesterolaemia should have DNA test, says NICE.
    BMJ; 2017 Nov; 359():j5112. PubMed ID: 29097374
    [No Abstract]   [Full Text] [Related]  

  • 28. What Is the Prevalence of Familial Hypercholesterolemia?
    Brunham LR; Hegele RA
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2629-2631. PubMed ID: 34433299
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
    Langslet G; Ose L
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Hopkins PN; Toth PP; Ballantyne CM; Rader DJ;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S9-17. PubMed ID: 21600530
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biotechnology and familial hypercholesterolemia].
    Tonstad S
    Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3124. PubMed ID: 9381451
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of gene mutations allows for the molecular diagnosis of familial hypercholesterolemia.
    Retief AE; Kotze MJ; Oosthuizen CJ
    S Afr Med J; 1989 Aug; 76(3):121. PubMed ID: 2762943
    [No Abstract]   [Full Text] [Related]  

  • 33. Targeted Screening of Familial Hypercholesterolemia in 11 Small Brazilian Cities: An Effective Approach to Detect Clusters of Affected Individuals.
    Izar MCO; Fonseca FAH
    Arq Bras Cardiol; 2022 Apr; 118(4):678-679. PubMed ID: 35508044
    [No Abstract]   [Full Text] [Related]  

  • 34. Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
    Knowles JW; Rader DJ; Khoury MJ
    JAMA; 2017 Jul; 318(4):381-382. PubMed ID: 28742895
    [No Abstract]   [Full Text] [Related]  

  • 35. Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Goldberg AC; Robinson JG; Cromwell WC; Ross JL; Ziajka PE
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S46-51. PubMed ID: 21600529
    [No Abstract]   [Full Text] [Related]  

  • 36. Application of the Japanese Guidelines for the Diagnosis of Familial Hypercholesterolemia in General Practice: It is to be Validated in International Harmonization.
    Tanaka N; Teramoto T; Yokoyama S
    J Atheroscler Thromb; 2019 Jan; 26(1):93-98. PubMed ID: 30487348
    [No Abstract]   [Full Text] [Related]  

  • 37. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.
    Warner M
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):114. PubMed ID: 18275690
    [No Abstract]   [Full Text] [Related]  

  • 38. Homozygous familial hypercholesterolemia.
    Diwan AG; Krishna KK; Jain MM; Arafat M; Sardesai VR; Dube MN
    J Assoc Physicians India; 2002 May; 50(5):738-9. PubMed ID: 12186142
    [No Abstract]   [Full Text] [Related]  

  • 39. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
    Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The problem of familial hypercholesterolemia].
    Pedro-Botet JC; Millán Núñez-Cortes J; Lahera Julia V; Vázquez Carrera M
    Clin Investig Arterioscler; 2013; 25(4):174. PubMed ID: 24183481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.